Editorial Podcasts

Vaccines and Virus Purification through the Ages

June 11, 2018

Learn Morewww.bio-rad.com/fluvaccine

The Transition from Paper Records to Electonic Batch Records

July 01, 2015

Dennis Brandl, President, at BR&L Consulting, spoke with BioPharm International about what should be expected when transitioning from paper to EBR.

Open Innovation: Transforming the Model of Biopharmaceutical R&D

April 15, 2013

Don Frail, Vice President, AstraZeneca Innovative Medicines Group discusses the company's approach to innovation and the upcoming session at the BIO International Convention

Opportunities and Challenges in Developing Stem Cell Therapies

April 02, 2013

A conversation with Armand Keating, the Epstein Chair in Cell Therapy and Transplantation at the University of Toronto prior to his presentation at Bio 2013

Big Pharma Leverages Early-Stage Risk with Innovative Options

April 02, 2013

In recent years, large pharmaceutical companies have launched a variety of initiatives to restock ailing pipelines and boost business performance including mergers and acquisitions, diversifying business portfolios to non-pharmaceutical products, downsizing, spinoffs, and entering the biopharmaceutical arena.

Podcast: Key Business Considerations for Growing BioPharm Product Pipeline

February 10, 2012

BioPharm International interviews Tarja Mottram, CEO of Action for Results, on the marriage of science and business to ensure sustainable growth. Posted Feb. 2012.

Podcast: 2012 Retrospective on Separations Technology

January 16, 2012

Mike Ultee, chief scientific officer of Laureate Biopharmaceutical Services, discusses advances in separations technology, beginning with the 1988 publication of ?Separations Technology Outlook, Part II? by Nancy E. Pfund and Kathleen G. Charles.